Gastric cancer is one of the malignant tumors with high mortality in China. Prediction of prognosis of the patients with advanced gastric cancer can benefit from accurate prognosis and individual treatment.
18
F-fluorodeoxyglucose (
18
F-FDG) PET/CT can provide both metabolic and morphological information
which becomes one of the most sensitive tools to stage
evaluate the efficacy of therapy and predict the outcomes of patients with malignancy. This paper reviews the predictive value of pretreatment and early
18
F-FDG PET/CT in prognosis for advanced gastric cancer.
Prediction of lymphovascular invasion using multiparametric MRI habitat radiomics based on machine learning algorithms in gastric cancer
Evaluation of prostate cancer across different treatment stages using 18F-FDG PET imaging
Site-specific development and preclinical evaluation of 68Ga-THP-ACN376, a CLDN18.2-targeted nanobody probe
In vitro and in vivo evaluation of targeted probe 68 Ga-NOTA-376 constructed by non-site-specific labeling method for CLDN18.2
Clinical value of DECT quantitative parameters in predicting lymph node metastasis of gastric cancer
Related Author
YANG Xiaotang
SONG Ruirui
CUI Yanfen
MA Shaoqing
WU Yanan
Li HUO
Hongli JING
Linfeng LI
Related Institution
Shanxi Medical University Graduate School
Department of Imaging, Shanxi Province Cancer Hospital /Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences /Cancer Hospital Affiliated to Shanxi Medical University
Department of Information Management, Shanxi Province Cancer Hospital /Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences /Cancer Hospital Affiliated to Shanxi Medical University
Clinical Medicine, Peking Union Medical College, Chinese Academy of Medical Sciences
Department of Nuclear Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College